Sheila A. Doggrell

47 Caronia Crescent
Lynfield, AUK, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 208 publications

Consideration of the use of nalbuphine in idiopathic pulmonary fibrosis-associated cough: to cough or not to cough so much?

Consideration of the use of nalbuphine in idiopathic pulmonary fibrosis-associated cough: to cough or not to cough so much?

Journal: Expert opinion on investigational drugs

Published: July 03, 2026

Is supplemental vitamin D useful in the clinically isolated syndrome (CIS) typical of multiple sclerosis?

Is supplemental vitamin D useful in the clinically isolated syndrome (CIS) typical of multiple sclerosis?

Journal: Expert opinion on pharmacotherapy

Published: April 21, 2026

Is seltorexant, an orexin-2 receptor antagonist, showing promise in insomnia?

Is seltorexant, an orexin-2 receptor antagonist, showing promise in insomnia?

Journal: Expert opinion on investigational drugs

Published: March 02, 2026

Does varenicline promote abstinence in youths who vape?

Does varenicline promote abstinence in youths who vape?

Journal: Expert opinion on pharmacotherapy

Published: November 20, 2025

Reply to: reframing guselkumab's benefit in ulcerative colitis: insights from QUASAR and emerging evidence.

Reply to: reframing guselkumab's benefit in ulcerative colitis: insights from QUASAR and emerging evidence.

Journal: Expert opinion on biological therapy

Published: November 18, 2025

With guselkumab, does the dual mechanisms to inhibit IL-23, help in ulcerative colitis?

With guselkumab, does the dual mechanisms to inhibit IL-23, help in ulcerative colitis?

Journal: Expert opinion on biological therapy

Published: May 21, 2025

Will elinzanetant, a neurokinin receptor antagonist, have a role in the treatment of hot flashes?

Will elinzanetant, a neurokinin receptor antagonist, have a role in the treatment of hot flashes?

Journal: Expert opinion on pharmacotherapy

Published: February 10, 2025

Are glucagon-like peptide-1 (GLP-1) receptor agonists useful in treating Parkinson's disease (PD)? Does the clinical trial with lixisenatide add anything?

Are glucagon-like peptide-1 (GLP-1) receptor agonists useful in treating Parkinson's disease (PD)? Does the clinical trial with lixisenatide add anything?

Journal: Expert opinion on investigational drugs

Published: January 26, 2025

Will zilebesiran, an RNA interference therapy, be effective, safe, and improve the treatment of hypertension?

Will zilebesiran, an RNA interference therapy, be effective, safe, and improve the treatment of hypertension?

Journal: Expert opinion on biological therapy

Published: November 04, 2024

Descriptive study showing the effect of small differences in entry scores on retention and success in six courses in nursing.

Descriptive study showing the effect of small differences in entry scores on retention and success in six courses in nursing.

Journal: BMC nursing

Published: May 06, 2024

Sibeprenlimab, which neutralizes A PRoliferation Inducing Ligand (APRIL), as a new approach to treating IgA nephropathy.

Sibeprenlimab, which neutralizes A PRoliferation Inducing Ligand (APRIL), as a new approach to treating IgA nephropathy.

Journal: Expert opinion on biological therapy

Published: April 20, 2024

More failure with solanezumab - this time in preclinical Alzheimer's disease.

More failure with solanezumab - this time in preclinical Alzheimer's disease.

Journal: Expert opinion on biological therapy

Published: February 28, 2024

Showing 1-12 of 208

Last Updated: 09/26/2026